众生药业：RAY1225注射液治疗肥胖/超重患者与2型糖尿病患者的III期临床试验正在推进中

Core Viewpoint - The company is actively advancing the Phase III clinical trial of RAY1225 injection for treating obesity/overweight patients and those with type 2 diabetes, showing promising results in earlier trials [1] Group 1: Clinical Trial Progress - The Phase III clinical trial of RAY1225 injection is currently in progress [1] - The Phase II clinical trial results indicate that RAY1225 injection significantly outperforms the placebo in weight loss, blood sugar reduction, and improvement of various cardiovascular-renal-metabolic risk factors [1]